Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Real-world impact on overall survival of oxaliplatin-based adjuvant chemotherapy in older patients with colorectal cancer in Mexico.
Authors
Marytere Herrera
Gastrointestinal Oncology Unit, Mexico City, Mexico
Marytere Herrera , Elizabeth García , Dr. Consuelo Diaz , Erika Ruiz-Garcia , Sayako Miyagui Adame , Stefan Zilli Hernandez , Mextli Lopez , Berenice Carbajal , German Calderillo Ruiz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 61)
DOI
10.1200/JCO.2024.42.3_suppl.61
Abstract #
61
Poster Bd #
E4
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Impact of previous adjuvant oxaliplatin combination therapy on survival in elderly colorectal cancer patients with recurrence.
First Author: Yusuke Nagata
Poster
2020 ASCO Virtual Scientific Program
Phase II trial of adjuvant mFOLFOX6 after metastasectomy for pulmonary metastasis of colorectal cancer: WJOG5810G.
First Author: Nozomu Machida
Poster
2020 Gastrointestinal Cancers Symposium
Adjuvant chemotherapy (AC) for stage III colorectal cancer (CRC) in the elderly: An Irish experience.
First Author: Emily Harrold
Poster
2019 Gastrointestinal Cancers Symposium
Impact of cardiac comorbidity on use and outcomes of adjuvant chemotherapy (ADJ) for colorectal cancer (CRC): A real-world population-based study.
First Author: Shiru Lucy Liu